Tag: Medical Research Commercialisation Fund
Partnership between WA, Brandon BioCatalyst set to continue
The Western Australian government announced an additional $2.31 million for a further seven years, or until 2029, to continue its support for life science investment fund Brandon BioCatalyst, to which it has given $2.52 million since 2008.
Melbourne start-up MecRx secures $4 million investment to accelerate anti-cancer drugs discovery
A risk-sharing agreement with CSIRO saw Melbourne start-up biotech company MecRx secure a $4 million investment from the Medical Research Commercialisation Fund (MRCF) to...
Featured Article
Navigating energy price volatility with predictive intelligence
Energy price volatility has become a structural feature of modern electricity markets rather than a temporary disruption. For energy-intensive manufacturers and large commercial operators, fluctuating wholesale prices are reshaping how energy costs are managed, making reactive approaches increasingly inadequate.
